You are here: Home » 2024 » Archives for June 2024

ADSK ANNOUNCEMENT: If You Have Suffered Losses in Autodesk, Inc. (NASDAQ: ADSK), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Autodesk, Inc. (NASDAQ: ADSK) between June 1, 2023 and April 16, 2024, both dates inclusive (the “Class Period”), shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 24, 2024.

If you purchased Autodesk securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

To join the Autodesk class action, go to https://rosenlegal.com/submit–form/?case_id=24019 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors.

Details of the case: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Autodesk, Inc. lacked adequate internal controls as a result of issues with its free cash flow and non–GAAP operating margin practices; and (2) as a result, defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against Autodesk, Inc.. The deadline to file a motion to be appointed as lead plaintiff is June 24, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, go to https://rosenlegal.com/submit–form/?case_id=24019.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9154584)

ALT ANNOUNCEMENT: If You Have Suffered Losses in Altimmune, Inc. (NASDAQ: ALT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class Period”), shareholders who want to serve as lead plaintiff for the class must file their motions with the court by July 5, 2024.

If you purchased Altimmune securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

To join the Altimmune class action, go to https://rosenlegal.com/submit–form/?case_id=22535 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 5, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors.

Details of the case: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Altimmune overstated the potential for its lead product candidate, pemvidutide, a glucagon–like peptide–1 (“GLP–1”), to stand out from competing GLP–1 agonists based on the drug’s efficacy and tolerability results observed in evaluating pemvidutide for the treatment of obesity (the “MOMENTUM Trial”); (2) accordingly, the MOMENTUM trial results were less significant to pemvidutide’s clinical, commercial, and competitive prospects than defendants had led investors to believe; (3) as a result of all the foregoing, defendants had overstated Altimmune’s prospects for finding a strategic partner to develop pemvidutide; and (4) as a result, Altimmune’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9154582)

AKRO ANNOUNCEMENT: If You Have Suffered Losses in Akero Therapeutics, Inc. (NASDAQ: AKRO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September 13, 2022 and October 9, 2023, both dates inclusive (the “Class Period”), shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 12, 2024.

If you purchased Akero common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

To join the Akero class action, go to https://rosenlegal.com/submit–form/?case_id=24557 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 25, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors.

Details of the case: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) approximately 20% of the patients enrolled in the SYMMETRY study, a trial that purportedly tested its  lead product candidate, efruxifermin (“EFX”) in patients with Non–alcoholic Steatohepatitis (“NASH”) induced cirrhosis, had cryptogenic cirrhosis and did not have definitive NASH at baseline; (2) the cryptogenic cirrhotic patients included in the SYMMETRY study did not have biopsy–proven compensated cirrhosis due to definitive NASH; (3) the results from the cryptogenic cirrhosis patients were to be excluded from the calculation of the NASH resolution secondary endpoints; (4) Akero had introduced a confounding factor into the SYMMETRY study’s design, materially influencing the study’s potential results and increasing the risks that the study would fail to meet its primary endpoint; (5) the SYMMETRY study did not align with U.S. Food & Drug Administration guidance for testing a drug in treating NASH cirrhotics because Akero had not ruled out potential causes of each patient’s cirrhosis other than NASH; and (6) consequently, Akero had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application, the likelihood that the SYMMETRY trial would be successful as measured by its primary endpoint, and the likelihood EFX would become a commercial treatment for NASH cirrhotics. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against Akero Therapeutics. The deadline to file a motion to be appointed as lead plaintiff is August 12, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, go to https://rosenlegal.com/submit–form/?case_id=24557.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9154577)

RBLX INVESTOR NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Roblox Corporation (NYSE: RBLX) between November 15, 2023 and May 8, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 12, 2024.

SO WHAT: If you purchased Roblox securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Roblox class action, go to https://rosenlegal.com/submit–form/?case_id=25991 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 12, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or created the false impression that they possessed reliable information pertaining to Roblox’s projected revenue outlook and anticipated bookings growth, due largely to expansions in Roblox’s available platforms, changes in Roblox’s digital technology (such as avatars), Roblox’s shared economy with content creators, and advertising revenue. In truth, Roblox knew each of those bookings and revenue sources were tenuous at best. In fact, Roblox faced difficulty converting daily average users (“DAUs”) into bookings and eventually blamed the very technology and platform growth it lauded as revolutionary and revenue–generating for this bookings problem. Defendants misled investors by providing the public with a materially flawed outlook for the relationship between DAU, bookings, and technology it lauded during its Investor Day and Earnings Call. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Roblox class action, go to https://rosenlegal.com/submit–form/?case_id=25991 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
case@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9154394)

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) between March 17, 2021 and May 7, 2024, both dates inclusive (the “Class Period”), of the important August 5, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Marinus securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Marinus class action, go to https://rosenlegal.com/submit–form/?case_id=25735 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 5, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) defendants understated the risk of failure to meet the early–stopping criteria in the RAISE trial; (2) defendants did not disclose that a possible consequence of failing to meet the early stopping criteria in the RAISE trial would be that Marinus would stop the separate Phase 3 RAISE II trial; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Marinus class action, go to https://rosenlegal.com/submit–form/?case_id=25735 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
case@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9154384)

Global Center on Adaptation and AUDA-NEPAD Sign Memorandum of Understanding to Accelerate Climate Change Adaptation in Africa

Rotterdam, June 14, 2024 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) and the African Union Development Agency (AUDA–NEPAD) signed a landmark memorandum of understanding (MoU) to collaborate on accelerating climate change adaptation efforts across Africa. Building on the AUC–GCA–AfDB Africa–led, Africa–owned Africa Adaptation Acceleration Program (AAAP), the partnership will support African member states to respond to the impact of the climate crisis.

The MoU establishes a framework for joint initiatives in such critical areas as access to climate adaptation finance, technical and institutional capacity building, climate–smart agriculture, sustainable land and water management, and disaster risk management inclusive the African Forest Landscape Restoration Initiative. The GCA and AUDA–NEPAD will also collaborate hand–in–hand to ensure full delivery on the $25 billion ambition of the AAAP by 2025 and to build the ground for even more ambitious follow–through beyond 2025.

Speaking at the signing ceremony at the GCA regional office in Rotterdam, GCA CEO Professor Patrick V. Verkooijen said: “We are delighted to formalize our collaboration with AUDA–NEPAD through this MoU. Together, we will work towards a climate–resilient Africa by leveraging our combined expertise and resources to support innovative climate adaptation actions on the ground. AAAP is the world’s largest climate adaptation program and the full delivery on the $25 billion ambition it by 2025 is crucial to keeping Africa safe from the escalating impacts of the climate crisis. This partnership is a significant step in our mission to accelerate climate adaptation solutions for Africa.”

Ms. Nardos Bekele–Thomas, CEO of AUDA–NEPAD said: “This MoU with the Global Center on Adaptation marks a pivotal moment in our efforts to build a resilient Africa. We are going to galvanize and double down on progress to fully deliver the Africa Adaptation Acceleration Program, as well as to take it to the next stages with the full engagement of Africa. By pooling our strengths, we will enhance the capacity of African countries to adapt to climate change, ensuring sustainable development and improved livelihoods for all. We look forward to a fruitful collaboration that will drive impactful adaptation initiatives across the continent.”

Key areas of cooperation outlined in the MoU include:

  1. Access to Climate Adaptation Finance: enhancing access to international climate finance for adaptation projects in Africa.
  2. Climate adaptation and training: providing capacity–building initiatives to strengthen adaptation planning and implementation at the local level.
  3. Institutional Support and collaboration: supporting the programmatic activities of the AUDA–NEPAD Centre on Climate Resilience and Adaptation.
  4. Climate–Smart Agriculture: promoting climate–smart technologies to improve agricultural productivity and food security.
  5. Sustainable Land and Water Management: scaling up nature–based practices to manage land degradation and drought.
  6. Building Resilience and Addressing Fragility and Food Insecurity in Rural Settings: mainstreaming climate adaptation jobs in youth–led enterprises with innovative climate adaptation and resilience solutions; and supporting access to digital advisory services and scalable investments for improved and resilient livelihoods linked to the energy–water–food nexus in rural areas.
  7. Support African Member States on Disaster Risk Management: increasing integration of disaster risk reduction in regional and national sustainable development frameworks and testing risk–informed preparedness plans.
  8. Support for African Forest Landscape Restoration Initiative: providing technical capacity to accelerate agroforestry investments to restore degraded landscapes and build resilient communities.
  9. Infrastructure Resilience: enhancing the resilience of infrastructure projects against climate impacts through capacity building and the identification of priority adaptation projects.

The GCA and AUDA–NEPAD will also jointly organize events and advocacy initiatives to promote climate adaptation. This includes participation in such continental and global climate forums as the United Nations Framework Convention on Climate Change (UNFCCC) Africa Climate Weeks and the GCA Annual Climate Adaptation Summit.

Notes to Editors
About the Global Center on Adaptation
The Global Center on Adaptation (GCA) is an international organization that promotes adaptation to the impacts of climate change. It works to climate–proof development by instigating policy reforms and influencing investments made by international financial institutions and the private sector. The goal is to bring climate adaptation to the forefront of the global fight against climate change and ensure that it remains prominent. Founded in 2018, GCA embodies innovation in its approach to climate adaptation as well as in its physical presence. It operates from the largest floating office in the world, in Rotterdam, the Netherlands. Together with the African Union Commission, the African Development Bank and partners, the GCA is spearheading the world’s largest adaptation program, the Africa Adaptation Acceleration Program (AAAP), which aims to shape $25 billion in climate proofed development investments by 2025. GCA has a worldwide network of regional offices in Abidjan, Côte d’Ivoire; Dhaka, Bangladesh; and Beijing, China. The GCA will open a new Africa Headquarters in Nairobi, Kenya in 2025.

About the African Union Development Agency
African Union Development Agency–NEPAD (AUDA–NEPAD) is the development agency of the African Union. It is mandated by the Assembly of Heads of State and Government to coordinate and execute priority regional and continental projects to promote regional integration towards the accelerated realization of Agenda 2063. Its other objectives are to strengthen the capacity of African Union Member States and regional bodies, advance knowledge–based advisory support, undertake the full range of resource mobilization and serve as the continent’s technical interface with all Africa’s development stakeholders and development partners.

Attachment


GLOBENEWSWIRE (Distribution ID 9154133)

Sawantwadi’s Traditional Handmade Toys Struggle for Survival

Sawantwadi in Maharashtra, on the western coast of India, bordering Goa, has always been known for its wooden toys. A picturesque town amid hills and lush greenery, Sawantwadi retains an old-world charm to this day.  The regal Sawantwadi Palace holds pride of place, with colleges, schools, and temples cloistered around the periphery of the lake, […]

Nikkiso Clean Energy & Industrial Gases Group kündigt Wechsel des CEO zum 1. Juli 2024 an

TEMECULA, Kalifornien, June 14, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376) hat heute nach einer Abstimmung im Verwaltungsrat bekannt gegeben, dass Adrian Ridge mit Wirkung vom 1. Juli 2024 die Nachfolge von Peter Wagner als Chief Executive Officer der Nikkiso Clean Energy & Industrial Gases Group (Teil der Nikkiso Industrial Division) antreten wird. Wagner wird weiterhin im Verwaltungsrat der Nikkiso CE&IG Group als Executive Chairman tätig sein.

Als CEO wird Ridge, der derzeit Executive Vice President, Operations and Manufacturing bei der Nikkiso CE&IG Group ist, die operativen und finanziellen Ergebnisse vorantreiben und die Gruppe für zukünftiges Wachstum vorbereiten. Wagners neue Rolle als Executive Chairman wird sich darauf konzentrieren, die Vision und die langfristige Strategie der Gruppe in einer beratenden Funktion voranzutreiben.

„In den sechs Jahren der Führung von Herrn Wagner hat Nikkiso CE&IG sein Geschäft mehr als vervierfacht und ist für weiteres starkes Wachstum positioniert“, so Toshihiko Kai, President und CEO von Nikkiso. „Ich möchte ihm für seine Führungsqualitäten danken und Herrn Ridge als neuen CEO der Gruppe willkommen heißen.“

Bevor er 2018 zu Nikkiso kam, war Wagner CEO und Managing Director bei der LEWA Group. Ridge kam 2022 zu Nikkiso, nachdem er rund 30 Jahre bei Atlas Copco in verschiedenen Führungspositionen tätig war.

Über Nikkiso Co. Ltd.

Seit seiner Gründung im Jahr 1953 hat Nikkiso zur Lösung sozialer Probleme beigetragen, indem es den Wandel der Zeit mit Technologien und Produkten vorweggenommen hat, die weltweit und in Japan einmalig sind. Im Industriegeschäft hat Nikkiso neue Märkte durch die Entwicklung von Produkten im Energiebereich, von Produkten für die Hämodialyse im medizinischen Bereich und von CFK (kohlenstofffaserverstärktem Kunststoff) in der Luft– und Raumfahrt geschaffen.

Über die Nikkiso Clean Energy & Industrial Gases Group

Die Nikkiso Clean Energy & Industrial Gases Group ist ein führender Anbieter von kryogenen Anlagen, Technologien und Anwendungen für die Marktsegmente saubere Energie und Industriegase. Die Gruppe beschäftigt mehr als 1.600 Mitarbeiter in 22 Ländern und wird von Cryogenic Industries, Inc. in Südkalifornien, USA, geleitet, einer hundertprozentigen Tochtergesellschaft von Nikkiso Co, Ltd. (TSE: 6376).

Medienkontakt
Lisa Adams
+1 405 492 1689


GLOBENEWSWIRE (Distribution ID 9153970)

Nikkiso Clean Energy & Industrial Gases Group Anuncia Transição de CEO para o dia 1º de julho de 2024

TEMECULA, Califórnia, June 14, 2024 (GLOBE NEWSWIRE) — A Nikkiso Co., Ltd. (TSE: 6376), após uma votação do Conselho hoje anunciou que a partir de 1º de julho de 2024, Adrian Ridge sucederá a Peter Wagner como CEO da Nikkiso Clean Energy & Industrial Gases Group (parte da Divisão Industrial da Nikkiso). Wagner permanecerá no Conselho como Presidente Executivo do Nikkiso CE&IG Group.

Como CEO, Ridge, que atualmente é Vice–Presidente Executivo de Operações e Manufatura do Nikkiso CE&IG Group, impulsionará os resultados operacionais e financeiros e preparará o Grupo para o crescimento futuro. A nova função de Wagner como Presidente Executivo se concentrará em impulsionar a visão e a estratégia de longo prazo do Grupo na qualidade de consultor.

“Em seis anos sob a liderança de Peter, a Nikkiso CE&IG mais do que quadruplicou os negócios e está posicionada para um forte crescimento contínuo”, disse Toshihiko Kai, Presidente e CEO da Nikkiso. “Queremos agradecer a sua liderança e dar as boas–vindas a Adrian como novo CEO do Grupo.”

Antes de ingressar na Nikkiso em 2018, Wagner foi CEO e Diretor de Marketing do LEWA Group. Ridge ingressou na Nikkiso em 2022, após aproximadamente 30 anos na Atlas Copco onde atuou em vários cargos de liderança.

Sobre a Nikkiso Co. Ltd.

Desde a sua criação em 1953, a Nikkiso contribuiu para resolver questões sociais, antecipando as mudanças com tecnologias e produtos pioneiros no mundo e no Japão. No âmbito industrial, a Nikkiso criou novos mercados ao desenvolver produtos no campo da energia, produtos relacionados à hemodiálise para a indústria médica, e aeroestruturas de CFRP (plástico reforçado com fibra de carbono) para a indústria aeroespacial.

Sobre a Nikkiso Clean Energy & Industrial Gases Group

Nikkiso Clean Energy & Industrial Gases Group é um fornecedor líder de equipamentos criogênicos, tecnologias e aplicações para os segmentos de mercado de energia limpa e gás industrial. O Grupo emprega mais de 1.600 pessoas em 22 países e é liderado pela Cryogenic Industries, Inc., uma subsidiária integral da Nikkiso Co., Ltd. (TSE: 6376) no sul da Califórnia, EUA.

Contato com a Mídia
Lisa Adams
+1 405 492 1689


GLOBENEWSWIRE (Distribution ID 9153970)

Le groupe Nikkiso Clean Energy & Industrial Gases annonce un changement de direction au 1er juillet 2024

TEMECULA, Californie, 14 juin 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE : 6376) annonce ce jour qu’à l’issue d’une délibération du Conseil d’administration, Adrian Ridge succédera dès le 1er juillet 2024 à Peter Wagner à la présidence du groupe Nikkiso Clean Energy & Industrial Gases. Ce groupe fait partie de la branche industrielle de la maison mère. Monsieur Wagner conserve son siège au Conseil et y exercera les fonctions de Président exécutif du groupe Nikkiso CE&IG.

À la présidence du Conseil d’administration, Monsieur Ridge, actuellement Vice–président exécutif de l’exploitation et de la branche industrielle du groupe Nikkiso CE&IG, veillera à en piloter les performances opérationnelles et financières et à préparer le groupe pour sa future vague de croissance. Sous sa nouvelle casquette de Président exécutif, Monsieur Wagner se concentrera sur la vision et la stratégie à long terme du groupe et assumera le rôle de conseiller.

« Au cours des six ans du mandat de Peter Wagner, l’activité de Nikkiso CE&IG a plus que quadruplé et le groupe est en pole position pour enregistrer une croissance continue appuyée », observe Toshihiko Kai, Président et directeur général de Nikkiso. Et de conclure : « Je tiens à le remercier sincèrement pour sa direction, et j’accueille volontiers Adrian Ridge à la présidence du Conseil ».

Avant de rejoindre Nikkiso en 2018, Peter Wagner était PDG et directeur général du groupe LEWA, tandis qu’Alan Ridge a choisi Nikkiso en 2022 après avoir passé près de 30 ans chez Atlas Copco, où il a occupé divers postes de direction.

À propos de Nikkiso Co. Ltd.

Depuis sa création en 1953, Nikkiso a contribué à la résolution des conflits sociaux en anticipant les changements d’époque au moyen de technologies et de produits d’innovation parmi les premiers au monde et au Japon. Dans le secteur de l’industrie, Nikkiso a suscité de nouveaux marchés en développant des produits propres au domaine de l’énergie, des produits propres au domaine médical et liés à l’hémodialyse et des structures aériennes en polymère renforcé de fibres de carbone (ou PRFC) pour le compte de l’aérospatiale.

À propos du groupe Nikkiso Clean Energy & Industrial Gases

Le groupe Nikkiso Clean Energy & Industrial Gases est un fournisseur leader d’équipements cryogéniques et de technologies et d’applications conçues pour les marchés inhérents à l’énergie propre et aux gaz industriels. Il emploie plus de 1 600 collaborateurs répartis dans 22 pays et se place sous la tutelle de Cryogenic Industries, Inc., une entreprise située au sud de l’État californien des États–Unis, elle–même une filiale en propriété exclusive de Nikkiso Co., Ltd. (TSE : 6376).

Interlocutrice auprès des médias :
Lisa Adams
+1 405 492 1689


GLOBENEWSWIRE (Distribution ID 9153970)